Dynamics of Diabetes-Associated Autoantibodies in Young Children with Human Leukocyte Antigen-Conferred Risk of Type 1 Diabetes Recruited from the General Population
This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabet...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 90; no. 5; pp. 2712 - 2717 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Endocrine Society
01.05.2005
Copyright by The Endocrine Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2–4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P ≤ 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P ≤ 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive β-cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive β-cell autoimmunity. |
---|---|
AbstractList | This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2-4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P < or = 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P < or = 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive beta-cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive beta-cell autoimmunity. This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2–4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P ≤ 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P ≤ 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive β-cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive β-cell autoimmunity. This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2-4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P less than or equal to 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P less than or equal to 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive beta -cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive beta -cell autoimmunity. This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2 antibodies (IA-2A) in 1006 children recruited from the general population due to human leukocyte antigen (HLA) DQB1-conferred risk for type 1 diabetes (T1D). By the age of 5 yr, 13.8% of the children had had one or more autoantibodies in at least one sample drawn at 3- to 12-month intervals from birth, whereas 6.1% had had one or more of the three autoantibodies to biochemically defined antigens in at least two consecutive samples. The cumulative frequencies of positivity for at least two antibodies ranged from 3.2-4.4%. Seventy-five children (7.5%) had at least once ICA, 83 (8.3%) had IAA, 46 (4.6%) had GADA, and 33 (3.3%) had IA-2A. IAA were transient more frequently than the other antibodies (P < or = 0.03) and fluctuated between positivity and negativity more often than ICA (P = 0.001). The genetically high risk children were positive for each autoantibody reactivity more often (P < or = 0.03) than the moderate risk subjects. Thirteen of the 1006 children (1.3%) presented with T1D by the age of 5 yr. The most sensitive predictors of T1D were ICA and IAA, whereas the most specific predictor was IA-2A. Positivity for at least two autoantibodies of IAA, GADA, and IA-2A had the highest positive predictive value for T1D (34%). We conclude that the frequency of various diabetes-associated autoantibodies increases at a relatively stable rate at least up to the age of 5 yr. Persistent positivity for two or more autoantibodies appears to reflect destructive progressive beta-cell autoimmunity, whereas positivity for a single autoantibody may represent harmless nonprogressive or even regressive beta-cell autoimmunity. |
Author | Kimpimäki, T Simell, O Ilonen, J Kukko, M Korhonen, S Knip, M Simell, T Kupila, A Simell, S Veijola, R |
AuthorAffiliation | Juvenile Diabetes Research Foundation Center for the Prevention of Type 1 Diabetes in Finland (M.K., T.K., S.K., A.K., S.S., R.V., T.S., J.I., O.S., M.K.) and Medical School, University of Tampere, and Department of Pediatrics, Tampere University Hospital (M.K., T.K., M.K.), FI-33014 Tampere, Finland; Department of Pediatrics, University of Oulu (S.K., R.V.), FI-90014 Oulu, Finland; Departments of Pediatrics (A.K., S.S., T.S., O.S.) and Virology (J.I.), University of Turku, FI-20520 Turku, Finland; and Hospital for Children and Adolescents, University of Helsinki (M.K.), FI-00029 Helsinki, Finland |
AuthorAffiliation_xml | – name: Juvenile Diabetes Research Foundation Center for the Prevention of Type 1 Diabetes in Finland (M.K., T.K., S.K., A.K., S.S., R.V., T.S., J.I., O.S., M.K.) and Medical School, University of Tampere, and Department of Pediatrics, Tampere University Hospital (M.K., T.K., M.K.), FI-33014 Tampere, Finland; Department of Pediatrics, University of Oulu (S.K., R.V.), FI-90014 Oulu, Finland; Departments of Pediatrics (A.K., S.S., T.S., O.S.) and Virology (J.I.), University of Turku, FI-20520 Turku, Finland; and Hospital for Children and Adolescents, University of Helsinki (M.K.), FI-00029 Helsinki, Finland |
Author_xml | – sequence: 1 givenname: M surname: Kukko fullname: Kukko, M – sequence: 2 givenname: T surname: Kimpimäki fullname: Kimpimäki, T – sequence: 3 givenname: S surname: Korhonen fullname: Korhonen, S – sequence: 4 givenname: A surname: Kupila fullname: Kupila, A – sequence: 5 givenname: S surname: Simell fullname: Simell, S – sequence: 6 givenname: R surname: Veijola fullname: Veijola, R – sequence: 7 givenname: T surname: Simell fullname: Simell, T – sequence: 8 givenname: J surname: Ilonen fullname: Ilonen, J – sequence: 9 givenname: O surname: Simell fullname: Simell, O – sequence: 10 givenname: M surname: Knip fullname: Knip, M |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16779702$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15872335$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9v0zAYxi00xLrBjTPyBU7LsOPETo9VBxtSJdDYAU6W67xZ3CZ25z-q-oH4nnPUil2QsGX58nue57WfC3RmnQWE3lNyTUtKPm_0dUlIVVAm6Cs0o_OqLgSdizM0I6SkxVyUv87RRQgbQmhV1ewNOqd1I0rG6hn6c3OwajQ6YNfhG6PWECEUixCcNipCixcpOmWjWbvWQMDG4t8u2Ue87M3QerB4b2KP79KoLF5B2jp9iIAXWfEItlg624H32efehO2U8XDYAaZ_o_A9aJ_MlNR5N-LYA74FC14N-IfbpUFF4-xb9LpTQ4B3p_sS_fz65WF5V6y-335bLlaFroTghWK6XnOuBGFC1C1rKlJRUreCU6pUy3nHmjkRHc94pwlvGeh1KbSoSFuX7BJ9OrruvHtKEKIcTdAwDMqCS0FyIeYNpeS_IBWMZU-WwasjqL0LwUMnd96Myh8kJXJqT260nNqTU3sZ_3DyTesR2hf4VFcGPp4AFbQaOq-sNuGFmyYUZHpJdeT2bojgw3ZIe_CyBzXEXpK8Ki6aIifXeRNS5MN4lrGjDGzrtDcWdh5CkBuXvM3__u-pnwE9wsXc |
CODEN | JCEMAZ |
CitedBy_id | crossref_primary_10_2337_db11_0386 crossref_primary_10_2337_dc14_2426 crossref_primary_10_1016_j_autrev_2008_04_008 crossref_primary_10_1056_NEJMoa1004809 crossref_primary_10_3181_0701_RM_13 crossref_primary_10_1002_sim_9190 crossref_primary_10_1097_MPG_0b013e31805fc256 crossref_primary_10_1111_j_1399_5448_2011_00783_x crossref_primary_10_2337_diabetes_54_suppl_2_S125 crossref_primary_10_1016_j_jaut_2015_05_005 crossref_primary_10_2337_dc15_1027 crossref_primary_10_1210_clinem_dgaa624 crossref_primary_10_1007_s00125_017_4258_7 crossref_primary_10_1111_j_1399_5448_2012_00917_x crossref_primary_10_2337_db10_0186 crossref_primary_10_1111_cei_13391 crossref_primary_10_1016_j_diabet_2010_10_002 crossref_primary_10_12968_bjon_2016_25_6_330 crossref_primary_10_1515_jpem_2016_0030 crossref_primary_10_1017_S0007114520000744 crossref_primary_10_1016_S0140_6736_13_60591_7 crossref_primary_10_5812_jpr_157 crossref_primary_10_1097_01_med_0000235329_84906_3b crossref_primary_10_1017_S0007114513003073 crossref_primary_10_1111_pedi_12329 crossref_primary_10_1007_s00592_014_0673_0 crossref_primary_10_3389_fimmu_2022_909020 crossref_primary_10_1111_apm_12023 crossref_primary_10_12968_pnur_2017_28_1_28 crossref_primary_10_1111_j_1399_5448_2008_00369_x crossref_primary_10_1111_j_1399_5448_2008_00398_x crossref_primary_10_1016_j_jaut_2008_04_024 crossref_primary_10_1007_s00125_017_4410_4 crossref_primary_10_1007_s00428_021_03055_z crossref_primary_10_1210_jc_2019_01069 crossref_primary_10_2337_dc09_1217 crossref_primary_10_1056_NEJMc1100063 crossref_primary_10_1155_2012_457546 crossref_primary_10_3389_fmicb_2014_00361 crossref_primary_10_1016_S1155_1941_07_46585_4 crossref_primary_10_1007_s11892_012_0310_7 crossref_primary_10_1007_s00125_006_0225_4 crossref_primary_10_1016_j_coi_2005_09_013 crossref_primary_10_1111_pedi_12697 crossref_primary_10_1002_dmrr_998 crossref_primary_10_3390_ijms22147493 crossref_primary_10_1089_dia_2021_0554 crossref_primary_10_1016_j_dsx_2012_08_006 crossref_primary_10_2337_dc06_0711 crossref_primary_10_1016_S0140_6736_08_61309_4 crossref_primary_10_1007_s00125_016_4177_z crossref_primary_10_3109_08916934_2015_1134509 crossref_primary_10_1007_s00125_010_1734_8 crossref_primary_10_2337_dc07_1457 crossref_primary_10_1111_pedi_12023 crossref_primary_10_1111_pedi_12386 crossref_primary_10_2337_db13_0620 crossref_primary_10_1038_ejcn_2010_75 crossref_primary_10_1530_EJE_15_0674 crossref_primary_10_1016_j_cellimm_2011_12_008 crossref_primary_10_1007_s00281_017_0665_6 crossref_primary_10_1097_MPG_0000000000001293 crossref_primary_10_1016_j_jcyt_2016_06_006 crossref_primary_10_1007_s00125_008_1107_8 crossref_primary_10_1111_j_1399_5448_2008_00415_x |
Cites_doi | 10.1111/j.1399-0004.1984.tb01100.x 10.1038/371130a0 10.1126/science.3287615 10.1007/s00125-002-0949-8 10.1111/j.1365-2362.1996.tb02126.x 10.2337/diabetes.48.3.460 10.2337/diab.43.7.843 10.1006/jaut.1997.0154 10.1210/jc.2002-020018 10.2337/diab.41.12.1570 10.1016/S0140-6736(74)90140-8 10.3109/07853899708999375 10.1046/j.1464-5491.1999.00186.x 10.1007/s001250051067 10.1016/S0140-6736(01)05415-0 10.1007/s001250050925 10.2337/diabetes.50.11.2625 10.1172/JCI14257 10.2337/diabetes.51.3.646 10.2337/diacare.22.12.2049 10.1007/s001250051616 |
ContentType | Journal Article |
Copyright | Copyright © 2005 by The Endocrine Society 2005 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2005 by The Endocrine Society – notice: 2005 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TS H94 7X8 |
DOI | 10.1210/jc.2004-1371 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Physical Education Index AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Physical Education Index MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | 2717 |
ExternalDocumentID | 10_1210_jc_2004_1371 15872335 16779702 00004678-200505000-00036 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 02 08R 0R 1TH 29K 2WC 34G 39C 3O- 3V. 4.4 48X 53G 55 5GY 5RS 5YH 7X7 88E 8F7 8FI 8FJ AABJS AABMN AAIMJ AAJQQ AAPQZ AAQQT AAUQX AAWTL AAYJJ ABFLS ABOCM ABPMR ABPPZ ABSAR ABUWG ACGFS ACIMA ACPRK ACUTJ ADBBV ADBIT ADEIU ADGZP ADHKW ADRTK AELNO AELWJ AEMDU AENEX AENZO AETBJ AEWNT AFCHL AFFNX AFKRA AFRAH AFXEN AGINJ AGKRT AGVJH AHMBA AIKOY AIMBJ ALMA_UNASSIGNED_HOLDINGS APIBT AQKUS ARIXL ASMCH ASPBG AVWKF AYOIW AZFZN AZQFJ BAWUL BAYMD BBAFP BCRHZ BENPR BEYMZ BGYMP BHONS BPHCQ BSWAC BTRTY BVXVI C45 CDBKE CS3 D-I DAKXR DIK DPPUQ E3Z EBS EIHJH EJD ENERS F5P FEDTE FH7 FHSFR FOTVD FQBLK FYUFA G8K GAUVT GJ GJXCC GX1 H1 H13 HVGLF HZ H~9 IAO IHR INH J5H KBUDW KOP KQ8 KSN L7B M1P M5 MBLQV MHKGH N9A NLBLG NOYVH NVLIB O0- O9- OBH OCB ODMLO OGEVE OK1 OVD P2P PQEST PQQKQ PQUKI PRINS PROAC PSQYO REU ROX ROZ TCN TJX TLC TMA TWZ VH1 WOQ X X52 X7M XZ ZA5 ZGI ZXP ZY1 .XZ 3RD AJYGW M2M M5~ ROL ~H1 --- -~X .55 .GJ 08P 0R~ 18M 354 AABZA AACZT AAKAS AAPGJ AAPXW AAUGY AAVAP AAWDT ABBLC ABLJU ABPQP ABPTD ABWST ABXZS ACFRR ACGFO ACYHN ADGKP ADVEK ADZCM AERZD AFFZL AFGWE AFOFC AFXAL AFYAG AGQXC AGUTN AI. AJEEA ALXQX APJGH AQDSO BYORX CASEJ EMOBN FECEO FLUFQ FOEOM HZ~ IQODW KSI MJL N4W NOMLY OAUYM OBFPC OFXIZ OHH OPAEJ OVIDX P6G TEORI TR2 VVN W8F WHG YBU YFH YHG YOC YSK ~02 AARHZ AAUAY ABJNI ABMNT ABNHQ ABQNK ABXVV ACZBC ADQBN AGMDO ATGXG AVNTJ CGR CUY CVF ECM EIF ITC NPM OJZSN AAYXX CITATION 7T5 7TS H94 7X8 |
ID | FETCH-LOGICAL-c4776-a3c5b66a703775d38404105d7611aad66f38907f6c47fc06d3ecb27c740d523 |
ISSN | 0021-972X |
IngestDate | Fri Aug 16 08:32:25 EDT 2024 Fri Aug 16 23:52:07 EDT 2024 Thu Sep 12 16:26:00 EDT 2024 Sat Sep 28 07:43:22 EDT 2024 Sun Oct 22 16:06:29 EDT 2023 Thu Aug 13 19:45:25 EDT 2020 Tue Jan 05 21:44:36 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Endocrinopathy Human Autoimmunity Immunopathology Antibody Leukocyte Autoantibody Autoimmune disease Antigen Type 1 diabetes Dynamics Risk factor Child Endocrinology |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4776-a3c5b66a703775d38404105d7611aad66f38907f6c47fc06d3ecb27c740d523 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://academic.oup.com/jcem/article-pdf/90/5/2712/10776273/jcem2712.pdf |
PMID | 15872335 |
PQID | 17337403 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_67798110 proquest_miscellaneous_17337403 crossref_primary_10_1210_jc_2004_1371 pubmed_primary_15872335 pascalfrancis_primary_16779702 wolterskluwer_health_00004678-200505000-00036 endocrinepress_journals_10_1210_jc_2004_1371 |
ProviderPackageCode | .XZ OBH C45 5RS AFCHL OGEVE ~H1 ABPMR M5~ OVD OCB |
PublicationCentury | 2000 |
PublicationDate | 2005-May |
PublicationDateYYYYMMDD | 2005-05-01 |
PublicationDate_xml | – month: 05 year: 2005 text: 2005-May |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2005 |
Publisher | Endocrine Society Copyright by The Endocrine Society |
Publisher_xml | – name: Endocrine Society – name: Copyright by The Endocrine Society |
References | Bottazzo (2019041115290180900_R17) 1974; 2 Thai (2019041115290180900_R1) 1993; 1 Savola (2019041115290180900_R21) 1998; 41 Ziegler (2019041115290180900_R11) 1999; 48 Kimpimäki (2019041115290180900_R10) 2000; 85 Bertrams (2019041115290180900_R5) 1984 Sjöroos (2019041115290180900_R15) 1995; 18 Kimpimäki (2019041115290180900_R13) 2002; 87 Christie (2019041115290180900_R26) 1994; 43 Notkins (2019041115290180900_R3) 2001; 108 Greenbaum (2019041115290180900_R18) 1992; 41 Kupila (2019041115290180900_R14) 2001; 44 Savola (2019041115290180900_R24) 2001; 50 Atkinson (2019041115290180900_R4) 2001; 358 Davies (2019041115290180900_R6) 1994; 371 Savola (2019041115290180900_R20) 1998; 41 Nejentsev (2019041115290180900_R16) 1999; 16 Gardner (2019041115290180900_R25) 1999; 22 Leslie (2019041115290180900_R9) 1994; 43 Swets (2019041115290180900_R22) 1988; 240 Decochez (2019041115290180900_R27) 2002; 45 Kupila (2019041115290180900_R12) 2002; 51 Knip (2019041115290180900_R2) 1997; 29 Christie (2019041115290180900_R8) 1996; 26 Rotter (2019041115290180900_R7) 1984; 26 Williams (2019041115290180900_R19) 1997; 10 Yu (2019041115290180900_R23) 2000; 85 |
References_xml | – volume: 26 start-page: 529 year: 1984 ident: 2019041115290180900_R7 article-title: Measuring the genetic contribution of a single locus to a multilocus disease. publication-title: Clin Genet doi: 10.1111/j.1399-0004.1984.tb01100.x contributor: fullname: Rotter – volume: 371 start-page: 130 year: 1994 ident: 2019041115290180900_R6 article-title: A genome wide search for human type I diabetes susceptibility genes. publication-title: Nature doi: 10.1038/371130a0 contributor: fullname: Davies – volume: 240 start-page: 1285 year: 1988 ident: 2019041115290180900_R22 article-title: Measuring the accuracy of diagnostic systems. publication-title: Science doi: 10.1126/science.3287615 contributor: fullname: Swets – volume: 45 start-page: 1658 year: 2002 ident: 2019041115290180900_R27 article-title: IA-2 antibodies predict impending type I diabetes in siblings of patients. publication-title: Diabetologia doi: 10.1007/s00125-002-0949-8 contributor: fullname: Decochez – volume: 43 start-page: 1254 year: 1994 ident: 2019041115290180900_R26 article-title: Antibodies to 37K antigen but not to glutamate decarboxylase discriminate rapid progression to insulin-dependent diabetes mellitus in endocrine autoimmunity. publication-title: Diabetologia contributor: fullname: Christie – volume: 26 start-page: 827 year: 1996 ident: 2019041115290180900_R8 article-title: Islet cell autoantigens in type 1 diabetes. publication-title: Eur J Clin Invest doi: 10.1111/j.1365-2362.1996.tb02126.x contributor: fullname: Christie – volume: 48 start-page: 460 year: 1999 ident: 2019041115290180900_R11 article-title: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. publication-title: Diabetes doi: 10.2337/diabetes.48.3.460 contributor: fullname: Ziegler – volume: 43 start-page: 843 year: 1994 ident: 2019041115290180900_R9 article-title: Perspectives in diabetes: early environmental events as a cause of IDDM: evidence and implications. publication-title: Diabetes doi: 10.2337/diab.43.7.843 contributor: fullname: Leslie – volume: 10 start-page: 473 year: 1997 ident: 2019041115290180900_R19 article-title: A novel micro-assay for insulin autoantibodies. publication-title: J Autoimmun doi: 10.1006/jaut.1997.0154 contributor: fullname: Williams – volume: 85 start-page: 1126 year: 2000 ident: 2019041115290180900_R10 article-title: Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. publication-title: J Clin Endocrinol Metab contributor: fullname: Kimpimäki – volume: 87 start-page: 4572 year: 2002 ident: 2019041115290180900_R13 article-title: Natural history of β-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2002-020018 contributor: fullname: Kimpimäki – volume: 41 start-page: 1570 year: 1992 ident: 2019041115290180900_R18 article-title: Improved specificity of ICA assay in the Fourth International Immunology of Diabetes Serum Exchange Workshop. publication-title: Diabetes doi: 10.2337/diab.41.12.1570 contributor: fullname: Greenbaum – volume: 85 start-page: 2421 year: 2000 ident: 2019041115290180900_R23 article-title: Transient anti-islet autoantibodies: infrequent occurrence and lack of association with “genetic” risk factors. publication-title: J Clin Endocrinol Metab contributor: fullname: Yu – volume: 2 start-page: 1279 year: 1974 ident: 2019041115290180900_R17 article-title: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. publication-title: Lancet doi: 10.1016/S0140-6736(74)90140-8 contributor: fullname: Bottazzo – volume: 1 start-page: 1 year: 1993 ident: 2019041115290180900_R1 article-title: Natural history of IDDM. publication-title: Diabetes Rev contributor: fullname: Thai – volume: 29 start-page: 447 year: 1997 ident: 2019041115290180900_R2 article-title: Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus. publication-title: Ann Med doi: 10.3109/07853899708999375 contributor: fullname: Knip – start-page: 348 year: 1984 ident: 2019041115290180900_R5 article-title: Insulin-dependent diabetes mellitus publication-title: In: Albert ED, Baur MP, Mayr WR, eds. Histocompability testing. Berlin, Heidelberg, New York: Springer-Verlag; contributor: fullname: Bertrams – volume: 16 start-page: 985 year: 1999 ident: 2019041115290180900_R16 article-title: Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. publication-title: Diabet Med doi: 10.1046/j.1464-5491.1999.00186.x contributor: fullname: Nejentsev – volume: 41 start-page: 1293 year: 1998 ident: 2019041115290180900_R20 article-title: Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. publication-title: Diabetologia doi: 10.1007/s001250051067 contributor: fullname: Savola – volume: 358 start-page: 221 year: 2001 ident: 2019041115290180900_R4 article-title: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. publication-title: Lancet doi: 10.1016/S0140-6736(01)05415-0 contributor: fullname: Atkinson – volume: 41 start-page: 424 year: 1998 ident: 2019041115290180900_R21 article-title: IA-2 antibodies: a sensitive marker of IDDM with clinical onset in childhood and adolescence. publication-title: Diabetologia doi: 10.1007/s001250050925 contributor: fullname: Savola – volume: 50 start-page: 2625 year: 2001 ident: 2019041115290180900_R24 article-title: Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes: a population based study. publication-title: Diabetes doi: 10.2337/diabetes.50.11.2625 contributor: fullname: Savola – volume: 108 start-page: 1247 year: 2001 ident: 2019041115290180900_R3 article-title: Autoimmune type 1 diabetes: resolved and unresolved issues. publication-title: J Clin Invest doi: 10.1172/JCI14257 contributor: fullname: Notkins – volume: 51 start-page: 646 year: 2002 ident: 2019041115290180900_R12 article-title: Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. publication-title: Diabetes doi: 10.2337/diabetes.51.3.646 contributor: fullname: Kupila – volume: 22 start-page: 2049 year: 1999 ident: 2019041115290180900_R25 article-title: Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? publication-title: Diabetes Care doi: 10.2337/diacare.22.12.2049 contributor: fullname: Gardner – volume: 18 start-page: 870 year: 1995 ident: 2019041115290180900_R15 article-title: Triple-label hybridization assay for type I diabetes-related HLA alleles. publication-title: Biotechniques contributor: fullname: Sjöroos – volume: 44 start-page: 290 year: 2001 ident: 2019041115290180900_R14 article-title: Feasibility of genetic and immunological prediction of type 1 diabetes in a population based cohort. publication-title: Diabetologia doi: 10.1007/s001250051616 contributor: fullname: Kupila |
SSID | ssj0014453 |
Score | 2.2025416 |
Snippet | This study characterized the dynamics of islet cell antibodies (ICA), insulin antibodies (IAA), glutamic acid decarboxylase antibodies (GADA), and IA-2... |
SourceID | proquest crossref pubmed pascalfrancis wolterskluwer endocrinepress |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2712 |
SubjectTerms | Autoantibodies - blood Biological and medical sciences Child Diabetes Mellitus, Type 1 - immunology Endocrinopathies Female Fundamental and applied biological sciences. Psychology Glutamate Decarboxylase - immunology HLA-DQ Antigens - genetics HLA-DQ beta-Chains Humans Insulin Antibodies - blood Male Medical sciences Vertebrates: endocrinology |
Title | Dynamics of Diabetes-Associated Autoantibodies in Young Children with Human Leukocyte Antigen-Conferred Risk of Type 1 Diabetes Recruited from the General Population |
URI | http://dx.doi.org/10.1210/jc.2004-1371 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-200505000-00036 https://www.ncbi.nlm.nih.gov/pubmed/15872335 https://search.proquest.com/docview/17337403 https://search.proquest.com/docview/67798110 |
Volume | 90 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEOIN6Ux-IDnCAoTzs9Il4rKriwSL1FjuMsoW1StYnQ8n_4Efw7ZmznxbYScImq1Jq0mc_2zPibGUKeujKMmRShoyJfYOjGdYRUnhN7ErYfgFSYa7bFJ3byJfywiBaTya8Ba6mp05fyx968kv_RKtwDvWKW7D9othMKN-Az6BeuoGG4_pWO35h28pqN0QZRHWFfOFiSoqkreHNFWiFXEEMb5zi5xxnctk3fSjXLSp7XeJxQY4lOR-pkQOSnt_xzHa_1-ngtrJbbRtusXZbKmSlj_XzTNQYbmr8IykGtii4tU5VZBctX2ReEWqsa4LlqCxzqw6blshrFb-fFelOs9VF_aLpvd4zvebX9WpVqHNydN5tiJfoAbhvsiHpqYZd84Dkzrjuwdwu46TdqgRoNV2NuKNoXtgnwc3Gb0CUsQ8cLTBeYAWI2aw0ZL4q5H5h6Kn-U5W6_ukQu-3wWIZv0_aJjF4Gbagug2t9rcy4wYWr4WN0VyggaGUbX2vdu6NDI2BU70Eduuq3sc4dgzPcKGRa7pU6wGJhJpzfIdevf0FcGrDfJRJW3yJWPlsFxm_xsMUurnO7BLB1jlhYl1ZilLWYpYpZqzNIOs_QCZiliFp-BmKVe9yjaYZYiZilgllrM0h6zd8jnd29PX584tlWII0POmSMCGaWMCdi_OI-yIA5d5C9nnHmeEBljORjmLs8ZDM-ly7JAydTnkoduFvnBXXJUAijvE6ri0OOZn2exQE8hj6OMZSxwZQqLHVfRlDxrtZRsTD2YBP1oUGzyTWJT1zBBxU7Ji7EKEzu7dgeGH48U3MtmnM-460_Jk1bjCWwAeKonSlU1II4HAfyN4PAIFBGDmT8l9wxUeukWe1PijLCTmCTsREcQwJzFVRdcJVuFImAPDkp6SK728_YROaq3jXoMZnudHusJ8hu1T_Im |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dynamics+of+diabetes-associated+autoantibodies+in+young+children+with+human+leukocyte+antigen-conferred+risk+of+type+1+diabetes+recruited+from+the+general+population&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Kukko%2C+M&rft.au=Kimpim%C3%A4ki%2C+T&rft.au=Korhonen%2C+S&rft.au=Kupila%2C+A&rft.date=2005-05-01&rft.issn=0021-972X&rft.volume=90&rft.issue=5&rft.spage=2712&rft_id=info:doi/10.1210%2Fjc.2004-1371&rft_id=info%3Apmid%2F15872335&rft.externalDocID=15872335 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |